Sagefield Capital’s Checkpoint Therapeutics CKPT Stock Holding History

Sagefield Capital’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-167,800	Closed	-$678K	–	101
2025 Q1	$678K	Buy	+167,800	New	+$559K	0.08%	80

Sagefield Capital's CKPT Position: Q2 2025 in Review

Sagefield Capital sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 167,800 shares — an estimated $678K sold.

Sagefield Capital first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $678K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Sagefield Capital reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Sagefield Capital sold 167,800 Checkpoint Therapeutics shares in Q2 2025, an estimated $678K.
Sagefield Capital first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Sagefield Capital's Checkpoint Therapeutics position peaked at $678K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Sagefield Capital's 13F filing for Q2 2025, filed 14 Aug 2025.